Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0361020230660060422
Korean Journal of Otolaryngology - Head and Neck Surgery
2023 Volume.66 No. 6 p.422 ~ p.425
A Novel Technique: Ultrasonography-Guided Botulinum Toxin Injection in Adductor Type Spasmodic Dysphonia
Lee Sang-Jae

Na Hyung-Gyun
Bae Chang-Hoon
Song Si-Youn
Kim Yong-Dae
Choi Yoon-Seok
Abstract
Spasmodic dysphonia (SD) is a rare disease caused by focal dystonia in the laryngeal muscles.
The adductor type SD (AdSD), which affects the thyroarytenoid (TA) muscle, is found in 80%of all SD patients. For them, voice therapy and medication are less effective and definitive sur-gical treatment has not been established yet. Botulinum toxin injection is considered the goldstandard treatment. However, patients require regular injections every 3-6 months wheneverthe effect of botulinum toxin disappears. Therefore, it is essential that injecting botulinumtoxin is safe, comfortable, and accurate. Injections are usually performed under the guidanceof electromyography or laryngoscopy. Ultrasonography (US) is a familiar device to otorhino-laryngologists and has recently been used to evaluate the laryngeal structures. While US hasbeen used only for diagnosis, it can also be used for treatment. Here, we describe a novel tech-nique that can be used to inject botulinum toxin into the TA muscle via trans-cartilaginousapproach under the guidance of US for the treatment of AdSD.
KEYWORD
Botulinum toxins, Dysphonia, Laryngeal muscles, Ultrasonography, Voice
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø